Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.4701
-0.0286-5.73%
Volume:66.56K
Turnover:31.92K
Market Cap:4.62M
PE:-0.03
High:0.4986
Open:0.4974
Low:0.4700
Close:0.4987
52wk High:49.25
52wk Low:0.4600
Shares:9.83M
Float Shares:9.82M
Volume Ratio:0.99
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.6157
EPS(LYR):-371.2241
ROE:-161.86%
ROA:-70.14%
PB:0.49
PE(LYR):0.00

Loading ...

Oct 05, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 17, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
May 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2026

Correspondence

Form CORRESP - Correspondence
Apr 10, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 20, 2026

Correspondence

Form CORRESP - Correspondence
Feb 19, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 17, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2026

Correspondence

Form CORRESP - Correspondence
Feb 11, 2026

Correspondence

Form CORRESP - Correspondence
Feb 02, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 07, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Correspondence

Form CORRESP - Correspondence
Dec 30, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report